Lasa Supergenerics has resumed production at its Mahad (MIDC) unit, following the major fire reported on April 26. The company had then said that the fire incident had resulted in the entire operations of the company being halted, including running batches in process. However, the orphaned batches in process were successfully rescued with no loss of yield and purity of product, it had said. The company did not suffer any operational loss and all the hard assets were intact with no major impact, Lasa said. Lasa Supergenerics is among the leading manufacturers of veterinary APIs in India through its catalyst chemistry expertise and fully backward integrated unit. Shares of Lasa Supergenerics gained 3.86 per cent at ₹76.65 on the NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.